Stem Cell Applications

Early human studies suggest that stem cell–based approaches may support vascular and neural health and improve erectile function in selected men. However, the evidence is limited and heterogeneous; these therapies are not standard of care and should be considered investigational.

After specialist assessment, research protocols may be discussed for vasculogenic ED (e.g., diabetes or atherosclerosis) and some cases of Peyronie’s disease with ED. Suitability is highly individualized and usually limited to controlled clinical settings.

Cells are commonly derived from the patient’s adipose tissue or bone marrow and processed in labs compliant with regulations/quality standards. Some centers study donor-derived products or exosomes within research protocols. Treatment is typically an intracavernosal injection under local anesthesia. Details (dose, cell numbers, session frequency) vary by protocol and local regulations; there is no consensus on a single “best” method yet.

Small clinical studies report improvements lasting several months to ~1 year (sometimes longer), but long-term durability remains uncertain. Some protocols schedule repeat sessions if benefits diminish. Outcomes vary with etiology and individual response.

No. The goal is to improve erection quality and blood flow, not length or girth. Expectations should focus on function. It may be planned as a supportive approach alongside fillers, but it is not a stand-alone thickening/enlargement method.

Short-term tolerability appears generally acceptable in early studies; possible effects include bruising, swelling, pain, infection, nodules/asymmetry, and rarely vascular events. Exosomes are tightly regulated in many countries; unapproved uses pose regulatory and safety risks. Choose experienced teams and discuss risks/benefits/alternatives in detail.

Availability varies. Legitimate offerings are usually within IRB-approved clinical trials or regulated research. Before proceeding, verify the protocol, lab standards, and regulatory status.

No single established success rate exists. Small studies report improvements in erectile function scores for some participants, but samples are small and methods vary. High-quality, randomized, placebo-controlled trials are needed to define efficacy and identify who benefits most.

No. Stem cell approaches do not replace evidence-based treatments. They may be discussed for selected patients who do not respond to or cannot use standard therapies—ideally within research settings. When other treatments fail, a penile prosthesis remains a definitive option with strong outcomes data.

Costs vary by center, protocol, and product. Insurance generally does not cover these therapies; many jurisdictions classify them as research or cosmetic. Confirm specifics with the center you plan to visit.